AR011452A1 -
A POLYPEPTIDE THAT INCLUDES AN IMMUNOGENIC PORTION OF AN ISOLATED M.VACCAE SOLUBLE ANTIGEN, OR A VARIANT OF THE SAME, AN ADISOLATED MOLECULA, A VECTOR OF EXPRESSION, A HOSPITAL CELL, A FUSION PROTEIN, A COMPOSITION THAT IS VACCINE, A
- Google Patents
A POLYPEPTIDE THAT INCLUDES AN IMMUNOGENIC PORTION OF AN ISOLATED M.VACCAE SOLUBLE ANTIGEN, OR A VARIANT OF THE SAME, AN ADISOLATED MOLECULA, A VECTOR OF EXPRESSION, A HOSPITAL CELL, A FUSION PROTEIN, A COMPOSITION THAT IS VACCINE, A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/873,970external-prioritypatent/US6001361A/en
Priority claimed from US08/997,362external-prioritypatent/US5985287A/en
Application filed by Genesis Res & Dev Corp LtdfiledCriticalGenesis Res & Dev Corp Ltd
Publication of AR011452A1publicationCriticalpatent/AR011452A1/en
Se proveen polipéptidos que comprenden una porcion inmunogénica de proteína soluble M.vaccae y moléculas de ADN que codifican tales polipéptidos. Se proveeademás una molécula de ADN aislada, un vector de expresion, una célula huésped, una proteínade fusion, una composicion farmacéutica que comprende dichopolipéptido, una vacuna, un método para incluir inmunidad protectora en un paciente, un método para detectar una infeccion micobacteriana en un paciente,un equipo de diagnostico, unmétodo para detectar una infeccion micobacteriana en una muestra biologica, un anticuerpo nonoclonal, un anticuerpo policlonal,un método para mejorar una respuesta inmune no específica a un antígeno y un fragmento inmunologicamente reactivo deun antíg eno M. vaccae aislado.Polypeptides comprising an immunogenic portion of soluble M.vaccae protein and DNA molecules encoding such polypeptides are provided. Also provided are an isolated DNA molecule, an expression vector, a host cell, a fusion protein, a pharmaceutical composition comprising a dichopolypeptide, a vaccine, a method of including protective immunity in a patient, a method of detecting a mycobacterial infection in a patient, a diagnostic kit, a method of detecting a mycobacterial infection in a biological sample, a nonoclonal antibody, a polyclonal antibody, a method to enhance a non-specific immune response to an antigen, and an immunologically reactive fragment of an isolated M. vaccae antigen .
ARP9801009851997-06-121998-03-05
A POLYPEPTIDE THAT INCLUDES AN IMMUNOGENIC PORTION OF AN ISOLATED M.VACCAE SOLUBLE ANTIGEN, OR A VARIANT OF THE SAME, AN ADISOLATED MOLECULA, A VECTOR OF EXPRESSION, A HOSPITAL CELL, A FUSION PROTEIN, A COMPOSITION THAT IS VACCINE, A
AR011452A1
(en)
A POLYPEPTIDE THAT INCLUDES AN IMMUNOGENIC PORTION OF AN ISOLATED M.VACCAE SOLUBLE ANTIGEN, OR A VARIANT OF THE SAME, AN ADISOLATED MOLECULA, A VECTOR OF EXPRESSION, A HOSPITAL CELL, A FUSION PROTEIN, A COMPOSITION THAT IS VACCINE, A
POLYPEPTIDES AND POLINUCLEOTIDES OF NEISSERIA MENINGITIDIS, A UNICELULAR GUEST, A METHOD TO PRODUCE A DNA SEQUENCE, A METHOD TO PRODUCE A POLYPEPTIDE, A METHOD TO ISOLATE ANTIGEN, A COMPOSITION OF A PREVIOUS ONE-TIME PROMISE
Polypeptide comprising an antigenic portion of an antigen of m. tuberculosis, dna molecule, recombinant expression vector, host cell, process for detection of m. tuberculosis in a biological sample, diagnostic kit, monoclonal antibody, polyclonal antibody, and fusion protein.
Polypeptide, DNA molecule, expression vector, host cell, pharmaceutical composition, vaccine, fusion protein, process for detecting tuberculosis in a patient, and diagnostic kit
Enzyme-linked immunosorbent assay with partially purified cytosoluble 28-kilodalton protein for serological differentiation between Brucella melitensis-infected and B. melitensis Rev. 1-vaccinated sheep
Polypeptide, DNA molecule, recombinant expression vector, host cell, process to detect infection by m. tuberculosis in a biological sample, diagnostic kit, monoclonal, and, polyclonal, and, fusion protein
METHODS TO DETECT THE T. CRUZI INFECTION, IN A BIOLOGICAL SAMPLE, A RECOMBINANT VECTOR OF EXPRESSION, A MODIFIED MICROORGANISM, A DIAGNOSTIC KIT, A PHARMACEUTICAL COMPOSITION FOR THE PREPARATION OF A MEDICINE PRODUCTION OF ANTIBODIES THAT LINK TO T. CRUZI.
A POLYPEPTIDE THAT INCLUDES AN IMMUNOGENIC PORTION OF AN ISOLATED M.VACCAE SOLUBLE ANTIGEN, OR A VARIANT OF THE SAME, AN ADISOLATED MOLECULA, A VECTOR OF EXPRESSION, A HOSPITAL CELL, A FUSION PROTEIN, A COMPOSITION THAT IS VACCINE, A
A LIPL32 EXTERNAL MEMBRANE PROTEIN LIPL32 POLYPEPTIDE, AN ISOLATED POLINUCLEOTIDE, AN EXPRESSION VECTOR, A GUED CELL, A METHODOPARA TO PRODUCE SUCH LIPL32 POLYPEPTIDE, USE OF A POLIPEPTIDE MANUFACTURER, A MANUFACTURED MANUFACTURE